InVivo Therapeutics gets a green light to reopen enrollment in a clinical study of its neuro-spinal scaffold for treating acute spinal cord injuries.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1C6zjeb
Cap comentari:
Publica un comentari a l'entrada